Start-up
ViGeneron GmbH
THE NEXT GENERATION GENE THERAPY COMPANY
About ViGeneron
ViGeneron is a next generation gene therapy company dedicated to develop the innovative medicines of the future. Our team seeks to solve the major limitations of current gene therapy approaches.
ViGeneron was founded in 2017 as a spin-off of the Ludwig-Maximilians-University (LMU) Munich.
- Founding: 2017
- Focus : Manufacturer
- Industry : Pharma
Product portfolio of ViGeneron
News about ViGeneron
Here you will find ViGeneron GmbH
See the theme worlds for related content
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
